Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 6 | 2016 | 755 | 0.660 |
Why?
|
| Exosomes | 2 | 2016 | 126 | 0.520 |
Why?
|
| Arteries | 1 | 2017 | 81 | 0.500 |
Why?
|
| Brain | 2 | 2021 | 1472 | 0.390 |
Why?
|
| Macrophages | 1 | 2015 | 529 | 0.350 |
Why?
|
| Aging | 1 | 2017 | 783 | 0.350 |
Why?
|
| Intracranial Hemorrhages | 2 | 2021 | 28 | 0.340 |
Why?
|
| MicroRNAs | 1 | 2015 | 518 | 0.310 |
Why?
|
| HIV Infections | 4 | 2016 | 2586 | 0.280 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2013 | 59 | 0.260 |
Why?
|
| Phagocytosis | 2 | 2021 | 86 | 0.200 |
Why?
|
| HIV Core Protein p24 | 1 | 2003 | 12 | 0.200 |
Why?
|
| Brain Infarction | 1 | 2021 | 22 | 0.180 |
Why?
|
| Microglia | 2 | 2021 | 208 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 455 | 0.180 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 44 | 0.170 |
Why?
|
| Hematoma | 1 | 2020 | 15 | 0.170 |
Why?
|
| Brain Stem Infarctions | 1 | 2020 | 1 | 0.170 |
Why?
|
| Cerebellar Diseases | 1 | 2020 | 3 | 0.170 |
Why?
|
| Virus Replication | 1 | 2003 | 318 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 104 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 2853 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.140 |
Why?
|
| Autopsy | 1 | 2017 | 48 | 0.130 |
Why?
|
| Neurons | 2 | 2021 | 1263 | 0.120 |
Why?
|
| Aged | 6 | 2021 | 8214 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 310 | 0.110 |
Why?
|
| Humans | 12 | 2022 | 43102 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 226 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 536 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2013 | 307 | 0.100 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 52 | 0.090 |
Why?
|
| Middle Aged | 5 | 2021 | 12222 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1723 | 0.080 |
Why?
|
| RNA, Viral | 2 | 2021 | 321 | 0.080 |
Why?
|
| Transport Vesicles | 1 | 2010 | 22 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 245 | 0.070 |
Why?
|
| Male | 6 | 2021 | 23409 | 0.070 |
Why?
|
| Female | 6 | 2022 | 24698 | 0.070 |
Why?
|
| Young Adult | 2 | 2017 | 5080 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 876 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 458 | 0.070 |
Why?
|
| Adult | 4 | 2021 | 13872 | 0.070 |
Why?
|
| Cell Line | 2 | 2010 | 1410 | 0.050 |
Why?
|
| Gene Products, gag | 1 | 2003 | 12 | 0.050 |
Why?
|
| Taq Polymerase | 1 | 2003 | 8 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2003 | 59 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2003 | 67 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 44 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 1180 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 1542 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 30 | 0.040 |
Why?
|
| Bacteremia | 1 | 2021 | 37 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 72 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 38 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 611 | 0.040 |
Why?
|
| Mutant Proteins | 2 | 2012 | 51 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2020 | 21 | 0.040 |
Why?
|
| Olivary Nucleus | 1 | 2020 | 2 | 0.040 |
Why?
|
| Cerebellar Nuclei | 1 | 2020 | 5 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 21 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 355 | 0.040 |
Why?
|
| Transfection | 2 | 2013 | 532 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2021 | 131 | 0.040 |
Why?
|
| Medulla Oblongata | 1 | 2020 | 42 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2020 | 52 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 652 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 206 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 372 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 386 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 655 | 0.040 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 14 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1455 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 758 | 0.030 |
Why?
|
| Virion | 1 | 2016 | 75 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 127 | 0.030 |
Why?
|
| China | 1 | 2015 | 229 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2676 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 97 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 57 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 189 | 0.020 |
Why?
|
| Static Electricity | 1 | 2012 | 86 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 678 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 182 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1621 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 272 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 506 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 148 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 229 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 423 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1612 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 188 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 671 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 25 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1082 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 209 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 296 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 296 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 1177 | 0.010 |
Why?
|
| United States | 1 | 2015 | 5205 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 6081 | 0.010 |
Why?
|
| Barbados | 1 | 2003 | 3 | 0.010 |
Why?
|
| HIV Protease | 1 | 2003 | 23 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2003 | 35 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2003 | 54 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 515 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 430 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 769 | 0.010 |
Why?
|